To evaluate a localized post-blast TrkB activation strategy using 7,8-dihydroxyflavone (7,8-DHF) delivered to the cochlea via nanoparticles in a mouse model of blast-induced hearing loss.
Key Findings:
Local delivery of 7,8-DHF accelerated functional recovery and improved ABR thresholds compared to vehicle treatment.
Histological analyses showed preserved inner hair cell density and reduced outer hair cell loss in 7,8-DHF treated mice.
The modified blast paradigm produced reproducible, pressure-dependent cochlear injury.
Interpretation:
Remove this section as it contains unsupported conclusions.
Limitations:
The study primarily focused on a mouse model, which may limit the generalizability of the findings to humans.
The long-term effects of 7,8-DHF treatment beyond one month were not assessed.
Conclusion:
Revise to avoid implications about the study's impact and focus on summarizing findings.
